SP01A

DRUG3 trials

Sponsors

Samaritan Pharmaceuticals, Inc

Conditions

HIV InfectionsHuman Immunodeficiency Virus

Phase 1

A Dose Response and Safety Study of Procaine HCl in HIV-Infected Patients

CompletedNCT00299338

Samaritan Pharmaceuticals, IncHIV Infections

Start: 1997-09-30End: 2001-09-30Target: 24Updated: 2006-04-03

Phase 2

A Study of an Oral Entry Inhibitor, SP01A, in Treatment-Experienced HIV-Infected Patients

Samaritan Pharmaceuticals, IncHIV Infections

Start: 2005-05-31Target: 32Updated: 2006-03-22

SP01A: The Study of an Oral Entry Inhibitor in Treatment-Experienced HIV Patients

Samaritan Pharmaceuticals, IncHIV Infections, Human Immunodeficiency Virus

Start: 2006-03-31Target: 60Updated: 2006-10-27